APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
7.69
-0.23 (-2.53%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close 7.92
Open 7.91
Bid 7.45 x 800
Ask 8.61 x 900
Day's Range 7.51 - 8.19
52 Week Range 5.80 - 8.89
Volume 587,369
Avg. Volume 265,523
Market Cap 261.751M
Beta (3Y Monthly) 0.18
PE Ratio (TTM) 3.99
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • Business Wire 5 days ago

    Apyx Medical Corporation Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Introduces Fiscal Year 2019 Outlook

    Advanced Energy Sales increase 40% year-over-year in Q4 and increase 71% year-over-year in FY’18

  • Business Wire last month

    Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced that financial results for the fourth quarter and fiscal year 2018 will be released after the market closes on Wednesday, March 13. To listen to the call by phone, interested parties may dial 844-507-6493 (or 647-253-8641 for international callers) and provide access code 5488443. Participants should ask for the Apyx Medical Corporation Call.

  • Business Wire 2 months ago

    Apyx Medical Corporation Announces the Promotion of Todd Hornsby to Executive Vice President

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today announced that Todd Hornsby has been promoted to Executive Vice President, effective January 2, 2019. Mr. Hornsby joined Apyx Medical in August, 2014, and held the position of Vice President and General Manager of Advanced Energy prior to his promotion. “Todd has done an excellent job leading the global sales and marketing efforts for our Advanced Energy business, specifically the commercialization of our Renuvion Cosmetic Technology in the U.S. cosmetic surgery market and in an increasing number of international markets as well,” said Charlie Goodwin, President and Chief Executive Officer.

  • Business Wire 2 months ago

    Apyx Medical Corporation Reports Preliminary Full Year and Fourth Quarter 2018 Revenue Results

    Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today reported preliminary revenue results for the full year and fourth quarter ended December 31, 2018.